Metabolic health is an increasingly prominent concern, attracting growing attention and research, particularly within the microbiome field. Akkermansia muciniphila, a key player in the gut microbiome, has emerged as a significant driver of both gut and metabolic health. It plays a pivotal role in supporting gut barrier integrity and the production of GLP-1, a hormone with profound metabolic benefits. Learn from Adam Perlman, MD, MPH, FACP, about the latest research uncovering the impact of keystone and novel probiotic strains on GLP-1 signaling, satiety, cravings, and probiotic avenues for metabolic support.
Key points:
• Learn the mechanisms by which the gut microbiome mediates metabolic health.
• Understand how the gut-metabolism axis plays a critical role in natural GLP-1 production.
• Learn the benefits of incorporating Akkermansia-based probiotics into clinical practice.
——————————————————————————————————
Are you a healthcare practitioner? Consider signing up with Fullscript!
https://router.fullscript.com/practitioner-signup/webinar
Please note this webinar was previously recorded and hosts will not be able to respond to questions or comments after the scheduled LIVE Fullscript webinar date.
Questions? Reach us at https://support.fullscript.com/
Make sure to follow us on:
Facebook | https://facebook.com/fullscript
Twitter | https://twitter.com/fullscriptHQ
Instagram | https://instagram.com/fullscript
Linkedin | https://linkedin.com/company/fullscript
© Fullscript 2025. All rights reserved.